+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 16Years +
All Genders
Healthy Volunteers
ID05376254

Three-Dimensional Assessment of Right Ventricular Function in Patients Undergoing Left Ventricular Assist Device Implantation

Led by University of Alberta · Updated on 2026-05-29

200

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

The trial investigates the use of 3D transesophageal echocardiography TEE to analyze the right ventricles function in patients undergoing left ventricular assist device LVAD implantation. LVADs help support the left ventricle in patients with severe heart failure. Because right ventricular failure after LVAD implantation is common and linked to complications, this study aims to better predict which patients are at higher risk by using advanced 3D imaging methods. Participants receive one of several types of left-sided LVADs, including HeartMate III, HeartWare HVAD, or Levitronix CentriMag devices. During the LVAD implantation procedure, 3D TEE images of the right ventricle are taken and analyzed. The study focuses on gathering detailed heart function data and does not involve additional treatments or interventions beyond standard device implantation. During the study, researchers collect various heart function measurements within 24 hours after implantation, such as ventricular strain, volumes, ejection fractions, and tricuspid annular plane systolic excursion. Secondary outcomes include monitoring clinical data and lab tests over 14 days post-implantation. Participants are observed for right ventricular function and related support needs. The study started in March 2022 and will continue through January 2027, involving no experimental treatments beyond imaging and data collection.

CONDITIONS

Brief Title

3D Assessment of RV Function in Patients Undergoing LVAD Implantation

Who Can Participate

Age: 16Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients receiving a left-sided HeartMate III LVAD
  • Patients receiving a left-sided HeartWare HVAD LVAD
  • Patients receiving a left-sided Levitronix CentriMag LVAD
  • Patients aged 16 years or older
Not Eligible

You will not qualify if you...

  • Missing hemodynamic data needed to calculate pulmonary artery pulsatility index or comprehensive echocardiographic images
  • Additional heart valve repair or replacement during LVAD implantation (tricuspid, mitral, or aortic)
  • Inability to close the sternum at the end of the procedure
  • Right ventricular mechanical support introduced at the same time as LVAD implantation
  • Poor image quality preventing 3D imaging protocol
  • Known contraindication to transesophageal echocardiography (TEE)
  • Inability to advance the probe into the mid-esophagus for imaging

Research Team

S

Surita Sidhu, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here